This paper reports on the causes and preventability of primary anaesthetic deaths in Western Australia between 1985 and 2008. In Western Australia, it is a legal requirement to report all deaths that occur within 48 hours of an anaesthetic and later deaths if an anaesthetic complication is implicated. A committee assesses whether an anaesthetic factor caused the death (a primary anaesthetic death) or contributed to the death (an anaesthesiarelated death). Of the 2361 deaths reported to the Committee over the 24-year period, 102 were considered anaesthesia-related and of these, 53 were considered a primary anaesthetic death. There were six main causes of primary anaesthetic death: failure to oxygenate; aspiration of gastric contents; adverse drug reaction; doserelated drug effect leading to an adverse cardiovascular event; intravascular injection of local anaesthetic; and injury related to an anaesthetic procedure or invasive monitoring. The most common cause was a dose-related drug effect leading to an adverse cardiovascular event. The medical condition of the patient was considered a significant contributing factor in 69% of the deaths and 72% were considered preventable. In the second 12-year period, there were fewer deaths overall (15 vs 38), proportionately fewer deaths related to failure to oxygenate (one vs six) and proportionately more deaths related to aspiration of gastric contents (four vs two). However, the percentage of deaths considered preventable was similar. These findings can be used to advise patients on anaesthetic risks, to educate anaesthetists about preventable deaths and to encourage the development of even safer anaesthetic drugs and techniques.
Anaesthesia-related mortality in developed countries is extremely low. In Australia, it is estimated that there is currently only about one anaesthesiarelated death for every 50,000 anaesthetics 1 . The rate for deaths in which anaesthesia is considered the primary cause of death is even lower: only about one in every 250,000 anaesthetics 1, 2 . However, anaesthesia is now very common. For example, recent data indicate that the number of episodes of anaesthesia care in Australia each year is equal to about 15% of the population 1,2 . This means that even with this low rate, there may still be 12 or more deaths from a primary anaesthetic cause in Australia each year and many hundred worldwide.
What are the main causes of primary anaesthetic deaths, are they always preventable and have they changed over the last 25 years or so? Unfortunately there are few recent published data on which to base answers to these questions. Australia has comprehensive processes in place in most states to identify and investigate anaesthesia-related deaths; but in most cases the information published focuses on the classification of the deaths rather than the aetiology [1] [2] [3] [4] [5] [6] [7] [8] . This means that while there is extensive information on the profile of anaesthetic mortality (e.g. age range, physical status, urgency of procedure, type of hospital, type of surgery, contributing factors, etc), there is less information on how anaesthesia actually caused the death.
The Anaesthetic Mortality Committee of Western Australia has received reports of deaths of patients occurring within 48 hours of receiving an anaesthetic (or when anaesthesia was implicated in the death irrespective of the time frame) as a legal requirement since 1980 9 and has accumulated a substantial database. Since 1985, it has contributed data to national triennial reports, the most recent being 2006-2008 [1] [2] [3] [4] [5] [6] [7] [8] . It has also previously published data independently on the incidence of anaesthetic mortality in Western Australia 10, 11 . However, it has never previously published data on the causes of primary anaesthetic deaths in Western Australia over this period. The aim of the current paper is therefore to report on the causes and preventability of deaths in which anaesthesia was considered the most likely primary cause in Western Australia over the 24-year period 1985-2008, with particular attention to the changes in causes and preventability that occurred between the first 12 years and the last 12 years of this period.
METHODS
Reports of all deaths classified by the West Australian Anaesthetic Mortality Committee as Category 1 of the National Health and Medical Research Council and later the Australian and New Zealand College of Anaesthetists classification of perioperative deaths 1, 3 (Table 1; i.e. where it is reasonably certain that death was caused by the anaesthesia or other factors under the control of the anaesthetist) from 1985 to 2008 were reviewed and the causes of death were identified. In addition, the Committee's assessment about whether the medical condition of the patient was a significant contributory factor (subcategory H) 1 and whether the death was non-preventable (no correctable factor in the anaesthetic management could be identified: subcategory G) 1 were recorded. Patients' age, gender, American Society of Anesthesiologists physical status (ASA PS) and urgency of procedure (i.e. elective vs urgent or emergent) were also identified for each death.
In Western Australia, it is a legal requirement for anaesthetists or others involved in the care of a patient who dies during or within 48 hours of the administration of an anaesthetic to report the death to the West Australian Anaesthetic Mortality Committee, irrespective of the presumed cause of death 9 . Moreover, if a death occurs after 48 hours of the administration of an anaesthetic, but is suspected of being anaesthesia-related, there is a similar requirement to report the death 9 . The role of the Committee is to determine whether there is a possible anaesthetic contributory factor in the death and where necessary to make recommendations to the Government of Western Australia Department of Health in order to improve anaesthetic safety in Western Australia. The Committee has broad representation from the anaesthesia community in Western Australia, as well as input from a general practitioner and a clinical nurse (and when necessary from a surgeon or obstetrician) 9 , and is afforded legal privilege and confidentiality under both the Health Act and the West Australian Health Services (Quality Improvement) Act 13 . The Committee assesses anaesthetists' reports and, where necessary, patients' medical records. In all cases consensus is reached using information that is de-identified in relation to the anaesthetist(s) involved, the hospital where the death occurred and the patient.
An estimate of the number of episodes of anaesthetic care in Western Australia between 1985 and 2008 (inclusive) was obtained by tallying the estimates presented in the national triennial reports from 1985 to 2008 [1] [2] [3] [4] [5] [6] [7] [8] .
Section 340Bl.1 of the West Australian Health Act provides permission for publication of de-identified determinations of the West Australian Anaesthetic Mortality Committee 9 . 
RESUlTS
From 1985 to 2008 there were 2361 deaths reported to the West Australian Anaesthetic Mortality Committee. Of these, 102 were considered to be anaesthesia-related (Categories 1, 2 or 3 of the National Health and Medical Research Council/ Australian and New Zealand College of Anaesthetists Mortality Classification, Table 1 ) 1,3 . Of these, 53 were considered to have had a primary anaesthetic cause (Category 1 only) 1, 3 . There were six broad causes of primary anaesthetic death: failure to oxygenate (n=7); aspiration of gastric contents (n=6); adverse (idiosyncratic) drug reaction (n=4); dose-related drug effect leading to an adverse cardiovascular event (n=29); intravascular injection of local anaesthetic (n=1); and injury related to an anaesthetic procedure or invasive monitoring (n=6) ( Table 2 ). While these describe the primary cause, in many cases survival would have been expected given adequate resuscitation. Therefore, implicit in each of these primary causes is the additional clause: '… and/or failure to provide appropriate resuscitation'.
Causes of primary anaesthetic deaths
Failure to oxygenate Seven deaths were attributed to prolonged severe hypoxia. The mean age of the patients was 43 years (range 25-69 years). Five patients were female. Four patients had been assessed as ASA PS 1, one as ASA PS 1E and the other two as ASA PS 2 and ASA PS 4E. Three patients had a history of difficult intubation or had features on clinical examination predictive of difficult intubation. These three patients sustained prolonged severe hypoxia as a result of a 'can't intubate, can't ventilate' scenario postanaesthesia induction. Another patient developed airway obstruction after extubation following an ear, nose and throat procedure, and could not be re-intubated or ventilated. One patient had a prolonged period of apnoea as a result of a missed disconnection from a ventilator. One patient had a prolonged period in which an hypoxic gas mixture had been inadvertently delivered. In both these latter two cases, the appropriate alarms were not in use or were non-functional at the time. Two of the seven patients died in the operating theatre, while the remainder were resuscitated in the operating theatre but died of complications related to their hypoxic episode several days later in an intensive care unit.
All of the deaths in this category were considered potentially preventable, i.e. it was considered that with more detailed preoperative assessment, a different airway technique or the use of appropriately functioning alarms, the deaths could have been prevented. In only two of the deaths was the medical condition of the patient considered a significant factor. Six of the seven deaths occurred in the first 12-year period.
Aspiration of gastric contents
There were six patients whose death was attributed to complications arising from aspiration of gastric contents during anaesthesia. The mean age of the patients was 75 years (range 62-88 years). Three patients were female. Three had been classified as ASA PS 3 and three as ASA PS 4. Four were undergoing urgent procedures and two, elective. In all six cases, the patients were considered to have had significant risk factors for reflux of gastric contents. Three patients aspirated during induction before tracheal intubation. None of them had had a rapid sequence intubation. One patient aspirated with a laryngeal mask airway in situ. One patient Table 2 Causes of primary anaesthetic mortality in Western Australia from 1985-2008 1985-1996 1997-2008 1985-2008 Failure to oxygenate 6 (H=1) 1 (H=1) 7 (H=2) H=number of deaths in which the medical condition of the patient was considered a significant factor, G=number of deaths in which no correctable factor could be identified. aspirated soon after extubation, which in the opinion of the Committee had occurred too early. One patient aspirated while being sedated for a procedure under local anaesthetic, when his airway reflexes had been temporarily lost. All the aspirations were considered preventable. In one patient with severe emphysema, the medical condition of the patient was considered a significant factor. The Committee felt that in this case, the amount aspirated was minimal and the severity of the deterioration was related to the severity of the emphysema. Two of the deaths occurred in the first 12-year period and four in the second.
Adverse drug reaction There were four deaths related to an adverse drug reaction (idiosyncratic). The mean age of the patients was 54 years (range 44-63 years). Three were considered ASA PS 3 and one, ASA PS 2. Two were female. None of the patients were undergoing an urgent procedure. One involved severe hyperkalaemia following suxamethonium; the patient had been in hospital with bed rest for some weeks prior. Another patient developed sustained hypotension following protamine administration post cardiopulmonary bypass, developed a myocardial infarction during the period of hypotension and later died. Another patient with underlying coronary artery disease developed a myocardial infarction during a period of sustained hypotension as a result of an adverse reaction to intravenous dextran. The remaining patient developed sustained hypotension during an intravenous infusion of iron. In three of the four cases, the medical condition of the patient was considered a significant factor. In two patients the death was considered not preventable; it was felt that the patients' underlying ischaemic heart disease had reduced their cardiovascular reserve such that death occurred despite appropriate resuscitative efforts. All of these cases occurred in the first 12year period.
Dose-related drug effect leading to an adverse cardiovascular event
The majority of deaths (29) were in this category. Ten patients were female. The cause of death was considered drug-related insofar as the adverse cardiovascular event occurred after administration of the drug and 'dose-related' insofar as the responses to the drug were not idiosyncratic. In all cases, there was an adverse cardiovascular event from which resuscitation was unsuccessful. There were nine myocardial infarctions, 17 cases of sustained hypotension, one sustained ventricular fibrillation and two cerebrovascular accidents. The cause of the adverse event was attributed to a dose-related haemodynamic effect of one or more anaesthetic agents. The deaths were attributed to an absolute drug overdose (n=1), relative drug overdose (n=18; where the medical condition of the patient was considered to be a significant factor) or to patient factors alone when the Committee felt that the safest doses possible had been given (n=10). Death occurred in the operating theatre in 14 cases, in a post-anaesthetic care unit in seven cases and in an intensive care unit in the remaining eight cases. Twenty-one of the deaths occurred in the first 12-year period and eight in the second.
Only one of the 29 patients was classified ASA PS 1. This was a teenage patient who suffered a cardiac arrest after a period of sustained hypotension during an ear, nose and throat procedure; the Committee felt that there had most likely been an absolute overdose of anaesthetic agent.
Only six other deaths from this cause occurred in patients <60 years of age. A 28-year-old ASA PS 3 patient with disseminated cancer developed sustained hypotension during a palliative orthopaedic procedure; the Committee could not fault the anaesthetic technique but recognised its primary role in the death. Four patients aged 40-50 years developed sustained hypotension leading to a cardiac arrest. One had been assessed as ASA PS 2E, but significant coronary artery disease was found at postmortem. The other three had been assessed as ASA PS 4: one had congestive cardiac failure and chronic renal failure; another had sustained a myocardial infarction a few days preoperatively that had been missed; the third and fourth both had known coronary artery disease and peripheral vascular disease and were undergoing a major vascular procedure. A 56-year-old obese patient developed sustained hypotension in the prone position, which was complicated by the loss of vascular access.
The remaining 22 patients were >60 years of age (range 62-93 years). One was classified ASA PS 2; 21 were classified ASA PS 3-4.
The myocardial infarctions (n=9) and the ventricular fibrillation (n=1) were thought to be due to intraoperative haemodynamic disturbances in patients with critical coronary artery disease. The remaining cases of sustained hypotension (n=11) were thought to be due to a dose-related effect of one or more anaesthetic agents in patients with reduced cardiovascular reserve and/or failure to provide appropriate resuscitation and/or the lack of response to appropriate resuscitative efforts. Two deaths were attributed to cerebrovascular accidents during anaesthesia, despite otherwise uncomplicated anaesthetics.
Intravascular injection of local anaesthetic
A healthy young adult woman developed a cardiovascular collapse following an injection of local anaesthetic via the caudal route. The Committee felt that the death was due to inadvertent intravascular injection of local anaesthetic causing the cardiovascular collapse. This death occurred in the first 12-year period.
Injury related to an anaesthetic procedure or invasive monitoring There were six deaths in this category. The mean age of the patients was 79 years (range 75-85 years). One was related to an arterial vascular injury that occurred during central venous cannulation in an ASA PS 2 anaesthetised patient, with an ensuing haemothorax, prolonged hypotension and inadequate resuscitation. One was related to another arterial vascular injury that occurred during insertion of an intercostal catheter to drain a pneumothorax in an ASA PS 3 patient. The pneumothorax had occurred during resuscitation from anaphylaxis. The patient recovered from the anaphylaxis, which was otherwise well managed, but the ensuing haemothorax was initially missed, resulting in prolonged hypotension. There was one death related to a bronchial tear sustained during insertion of a bougie in a patient with a tracheal tumour. The subsequent bleeding led to further respiratory compromise. Three deaths were related to rupture of a pulmonary artery during cardiopulmonary bypass, with major bleeding and haemodynamic and respiratory compromise. In all three patients, a perforation by a pulmonary artery catheter was considered the most likely cause. The Committee felt that the medical condition of the patient was a significant factor in five of the six deaths, the exception being the aortic injury during insertion of the central venous catheter. It found no fault with the anaesthetic management in the three cases of pulmonary artery rupture as all reasonable precautions had been taken.
Contributory factors in the primary anaesthetic deaths
Overall there were 39 primary anaesthetic deaths in which the patient's medical condition was considered a significant factor; among these there were 15 deaths in which the Committee could not identify a correctable factor.
The majority of patients were ≥60 years of age (39, 73%). Of these, 16 were ≥80 years, and of these, four were ≥90 years of age. Fourteen patients were ≤60 years of age (27%), and of these only six were ≤40 years of age. Table 3 shows the overall age distribution and the changes in relative proportions of ASA PS 3-4, subcategory H and subcategory G with age.
Only seven of the 53 patients were classified as ASA PS 1. Five were in the 'failure to oxygenate' category, one in the 'dose-related drug effect leading to an adverse cardiovascular event category' and one was caused by an 'intravascular injection of local anaesthetic'. All of these deaths were considered preventable. There were six patients who were classified as ASA PS 2: one each in the 'failure to oxygenate', 'adverse drug reaction' and 'injury related to an anaesthetic procedure or invasive monitoring' categories, and three in the 'dose-related drug effect leading to an adverse cardiovascular event' category. Only one of these deaths was considered non-preventable: an intraoperative brain-stem cerebrovascular accident despite apparent satisfactory anaesthetic management. The remaining patients were classified as ASA PS 3 or 4. There were no patients classified ASA PS 5. Eleven of the 53 patients were classified as urgent or emergent: two in the 'failure to oxygenate' category, four in the 'aspiration of gastric contents' category, six in the 'dose-related drug effect leading to an adverse cardiovascular event' category and one in the 'injury related to an anaesthetic procedure or invasive monitoring category.
DISCUSSION
In Western Australia between 1985 and 2008, there were six main causes of primary anaesthetic deaths: failure to oxygenate; aspiration of gastric contents; adverse drug reaction; dose-related drug effect leading to an adverse cardiovascular event; intravascular injection of local anaesthetic; injury related to an anaesthetic procedure or invasive monitoring; and/or failure to resuscitate from these causes. By far the most common cause (55%) was a dose-related drug effect leading to an adverse cardiovascular event. Overall, the medical condition of the patient was considered a significant factor in 69% of the deaths and 72% of the deaths were considered preventable. There were major differences between the first and second 12 years of the report (Table 1 ). In the second 12-year period, there were fewer deaths overall (15 vs 38), proportionately fewer deaths related to failure to oxygenate (one vs six) and proportionately more deaths related to aspiration of gastric contents (four vs two). However, the percentage of deaths considered preventable was similar (67 vs 73%). These findings can be used to advise patients on anaesthetic risks, to educate anaesthetists about preventable deaths and to encourage the development of safer anaesthetic drugs and techniques to reduce the incidence of deaths that are at present considered 'non-preventable'. While a fundamental role of anaesthetists is to ensure an appropriate depth of anaesthesia, the priorities are to first maintain an adequate airway, to protect the lungs and to ensure adequate breathing and circulation. Failure to maintain the airway, ensure adequate breathing or provide adequate oxygenation will result in prolonged hypoxia, which was the cause of seven deaths in the 24-year period. The deaths occurred in a younger age group and all were considered preventable. Fortunately, only one of the deaths occurred in the second 12-year period, suggesting that current strategies and monitoring techniques have proven beneficial.
With every induction of general anaesthesia there is a loss of protective airway reflexes with a risk of aspiration of stomach contents if regurgitation occurs. The consequences depend on the volume aspirated and its acidity, but at its most severe, aspiration can result in profound hypoxaemia, bronchospasm, respiratory distress syndrome and death. Therefore, ensuring an empty stomach, and if this is not possible, protecting the airway, are core duties of an anaesthetist. There were six deaths related to aspiration of gastric contents. All were considered preventable. Disturbingly, the number in the second 12-year period was higher than in the first, which was an opposite trend to all other causes.
It was of interest that there were no deaths related to adverse drug reactions in the second 12-year period, i.e. no deaths from anaphylaxis, malignant hyperthermia or other anaesthetic agent toxicity.
Although there were 29 deaths attributed to a dose-related effect of one or more anaesthetic drugs resulting in an adverse cardiovascular event, only one of these cases was considered an absolute overdose. In 18 cases, the Committee felt that there was a relative overdose of one or more anaesthetic agents and/or the resuscitation was suboptimal. In the remaining ten patients, the doses of all anaesthetic drugs and all resuscitative efforts were considered appropriate. Even though these cases were considered non-preventable, other than by withholding adequate anaesthesia, they were not considered 'inevitable'. Ideally it should be possible to provide safe anaesthesia for all patients, irrespective of their cardiovascular reserve. The recognition that some primary anaesthetic deaths cannot be prevented despite the optimal use of currently available anaesthetic drugs and techniques (including monitoring techniques) is an impetus for the development of safer anaesthetic drugs and techniques, and a justification for the ongoing research that this requires.
There was a single death due to an intravascular injection of local anaesthetic. This occurred in the first 12-year period. There were six deaths related to complications of anaesthetic monitoring equipment, but only two of which occurred in the second 12-year period. The reductions in the second 12-year period suggest that there has been improved safety during anaesthetic procedures and the application of invasive monitoring.
The preventability of primary anaesthetic deaths appeared to be related to the primary cause. For example, all deaths caused by failure to oxygenate and by aspiration of gastric contents were considered preventable. The single death, as a result of intravascular injection of local anaesthetic, was also considered preventable, both in relation to the ability to avoid the lethal intravascular injection and the inadequacy of the resuscitative effort. In contrast, ten of the 29 deaths caused by an adverse cardiovascular event (myocardial infarction, sustained hypotension, ventricular fibrillation or cerebrovascular accident) were considered 'non-preventable'. Similarly, two of the four deaths caused by an adverse drug reaction were considered non-preventable; in both cases the Committee felt that the resuscitative efforts had been adequate. The three remaining non-preventable deaths were all related to pulmonary artery rupture during cardiopulmonary bypass. The Committee felt that the management of the pulmonary artery catheters and the resuscitative efforts had been satisfactory, but the nature of the injury was lethal.
Although only 15 deaths overall were considered non-preventable, there were another 23 deaths in which the medical condition of the patient was considered a significant factor in the death. In this context, the 'medical condition of the patient' differs from the ASA PS because it is directly implicated in the death. In contrast, the ASA PS may or may not be directly implicated in the death. For example, an anatomical airway abnormality may not influence an ASA PS classification but may be a significant factor in an inability to oxygenate. Similarly, a patient may be classified as ASA PS 3 due to end-stage renal failure, but this may not be a significant factor in a purely airway problem. Nevertheless, there would be many instances when the ASA PS and the medical condition would coincide, such as ASA PS 3 or 4 patients who required cardiopulmonary resuscitation and who may not have responded normally to resuscitative efforts due to their reduced cardiopulmonary reserve.
There appeared to be a substantial decrease in the primary anaesthetic death rate between the first and second 12-year periods of this report. Over the total 24-year period (from the start of 1985 to the end of 2008) it is estimated that there were 6,356,000 episodes of anaesthesia care in Western Australia 1-8 . Therefore, with 53 primary anaesthetic deaths, the primary anaesthetic mortality death rate was 1:120,000 anaesthetics. However, the majority of the primary anaesthetic deaths occurred in the first 12 years (1985-1996; 38 deaths), during which there were about 2,556,000 anaesthetics (Table 1) , giving a rate of 1:67,000 anaesthetics. In contrast, from 1997-2008, there were only 15 primary anaesthetic deaths over about 3,800,000 anaesthetics for a rate of 1:250,000 anaesthetics, a nearly fourfold reduction.
There were also changes in the causes of the deaths between the first and second 12-year periods ( Table 1) . For example, there was only one death due to failure to oxygenate in the second 12-year period, compared to six in the first, and all four deaths due to adverse drug reactions were in the first 12 years. On the other hand, four of the six deaths due to aspiration occurred in the second 12-year period. There seemed little difference in the preventability of deaths between the two periods: 28 of 38 deaths in the first 12 years (73%), as opposed to ten of 15 (67%) in the second. These findings remain as observations because no statistical analysis was attempted.
These rates for primary anaesthetic mortality could be challenged on several grounds. First, the accuracy of the numerator could be questioned; however, it is a legal requirement for anaesthetists in Western Australia to report all deaths that occur within 48 hours of administration of an anaesthetic, as well as those thought to be a result of a complication occurring during the anaesthetic, irrespective of the interval between the anaesthetic and the death. Moreover, deaths occurring intraoperatively, in a post-anaesthesia care unit or early postoperatively in an intensive care unit that have no apparent surgical or other cause are extraordinarily rare and attract considerable attention. Furthermore, the death is likely to be investigated by the state coroner or come under other scrutiny. Under these circumstances, anaesthetists are highly unlikely to overlook their legal obligation to report the death to the Anaesthetic Mortality Committee. For these reasons, we are confident that the vast majority (if not all) of primary anaesthetic deaths were reported to the Anaesthetic Mortality Committee over this period.
The other potential criticism of the accuracy of these rates is the inevitable subjectivity introduced when attributing a primary anaesthetic cause to a death. While the fact of death and the receiving of an anaesthetic are both objective, attributing an anaesthetic cause to the death is always an opinion. Nevertheless, the opinions of the Anaesthetic Mortality Committee in Western Australia are based on the consensus of at least six anaesthetists, with mandatory input from one or more other health professionals. The cause of death is also determined using de-identified information, effectively eliminating the possibility of bias. There are also no disciplinary or other penalty implications from the determinations because all activity is confidential and protected by state legislation. For these reasons, we feel the degree of subjectivity and the possibility of bias in attributing an anaesthetic cause to a death were minimised.
Another consideration is the accuracy of the denominator (the number of anaesthetics administered). It is possible that the earlier estimates may be less accurate as they were extrapolated from surgical data, or based on a proportion of the population. However, more recent estimates have been based on specific anaesthesia codes collected by the Australian Institute of Health and Welfare and are likely to be more accurate 14 .
A further limitation is the 48-hour time period specified for the mandatory reporting of all deaths during or following an anaesthetic in Western Australia. It is possible that some later deaths could have been missed. However, if the anaesthetic had been uneventful and there had been 48 hours or more of apparent full recovery, it would be unlikely that the death would be considered a primary anaesthetic death. Moreover, if there had been an anaesthetic complication within the 48 hour period resulting in death after this period, there would still be a requirement to report the death. For this reason, we suspect that while we may have missed some anaesthesia-related deaths, few of these would have been considered a primary anaesthetic death.
While these results apply to Western Australia, it is likely that the findings would be similar in other states in Australia and other developed countries. Western Australia has a similar system of health delivery and funding as other Australian states and it is unlikely that the standard of anaesthesia care in Western Australia is either higher or lower than other areas of Australia or other developed countries.
There have been few other recent published Australian reports on causes of primary anaesthetic mortality with which to compare our findings. The most recent Victorian Consultative Council on Anaesthetic Mortality and Morbidity (VCCAMM) report (2003) (2004) (2005) lists airway, aspiration, hypoxia, myocardial infarction and pulmonary artery catheter as causes of primary anaesthetic mortality 15 , all of which we observed as primary causes in Western Australia. However, the VCCAMM report also includes three deaths related to anaphylaxis and one to malignant hyperthermia, whereas in Western Australia there were no deaths due to adverse drug reactions in the second 12-year period of the report. Also, none of the 12 primary anaesthetic deaths in the most recent VCCAMM report were considered to be caused by dose-related adverse cardiovascular events, whereas they classified 37 deaths due to an adverse cardiovascular event as 'inevitable'. There were similar differences in previous VCCAMM reports 15 . It is unclear whether these differences relate only to differences in classifications or reflect real differences in preventability and inevitability. like VCCAMM, the Special Committee Investigating Deaths under Anaesthesia in New South Wales also publishes detailed information of anaesthesia mortality, but does not specifically list causes of death 16 .
The first national triennial report on anaesthetic mortality in Australia (1985) (1986) (1987) included acid aspiration, airway obstruction, anaphylaxis, various dose-related adverse cardiovascular events and pulmonary artery rupture, among others, as principal causes of death in a sample of anaesthetic attributed deaths for the triennium 3 . Similarly, the second triennial report (1988) (1989) (1990) ) also included adverse drug reaction, airway obstruction, anaphylaxis, drug overdose (or inappropriate use) and aspiration in its list of principal causes of anaesthetic death 4 . Subsequent triennial reports have not specifically listed principal causes of death, focusing instead on more generic causal and contributory factors.
In summary, in Western Australia between 1985-2008, primary anaesthetic mortality was very low: about 1:67,000 anaesthetics for the first 12-year period, falling to about 1:250,000 anaesthetics for the second 12-year period. The most common cause was a dose-related drug effect leading to an adverse cardiovascular event. Other causes included failure to oxygenate, aspiration of gastric contents, adverse drug reaction, intravascular injection of local anaesthetic and injury related to an anaesthetic procedure or invasive monitoring. The medical condition of the patient was considered a significant factor in about two-thirds of the deaths, but less than one-third of the deaths were considered nonpreventable. In the second 12-year period, there was a lower proportion of deaths due to failure to oxygenate or adverse drug reaction, but proportionately more deaths due to aspiration of gastric contents. These findings indicate that anaesthetists in Western Australia have been very effective in reducing primary anaesthetic mortality. However, as over two-thirds of deaths remain preventable, there is an ongoing requirement for continuing education, quality improvement activities and other measures to further improve anaesthesia safety. Also, as many deaths are considered 'non-preventable' within our current state of knowledge, there is a need for further research to extend our knowledge and develop even safer anaesthesia drugs and techniques.
